These Naruto characters would adapt surprisingly well to the cursed world of Jujutsu Kaisen.

Crunchyroll is out with the nominations for its 10th annual Anime Awards. See the full list below. The Film of the Year category features 2025 anime smashes Chainsaw Man – The Movie: Reze Arc and ...

Winter is finally over, and the night is no longer dark and full of terrors. Instead, it’s full of new anime to watch. Spring has arrived with a wave of returning favorites, new original shows, and ...

Lucas Kloberdanz-Dyck is a writer for Collider. He grew up creating lists, stories, and worlds, which led to his love of anime and video games. He attended Sheridan College where he earned an Honours ...

A little more than a week after unveiling her solo band’s name was Blue Medusa, ex-Arch Enemy vocalist Alissa White-Gluz and company released the band’s new single, “Checkmate”. Written by White-Gluz ...

It starts quietly with 1.d4 and the tricky Benoni gambit. White accepts the pawn and launches the aggressive Nescafé Frappe Attack with Nb5 — a move that looks strange until it’s too late. Black grabs ...

Louis Kemner combines his love of creative writing with his passion for anime to craft some of the most compelling anime articles on the 'net. He's also a total gamer who has two decades of Magic: The ...

On Fox News, Thune said bluntly: “We will put the Democrats on the record! … And we will make sure the Democrats are on the record opposing the most basic requirement: ensuring only American citizens ...

How EGFR, ALK and PD-L1 biomarker results shape neoadjuvant lung cancer therapy—and what CheckMate-816 means for survival. Now let’s move to the CheckMate-77T trial, which evaluated perioperative ...

Google's Gemini artificial intelligence model has been growing its user base fast. The company is starting to close the gap with OpenAI's ChatGPT. While there were many preceding events that led to ...

Nvidia's DRIVE system is becoming popular among automakers developing autonomous driving technology. Tesla's future hinges on the company's ability to scale up its Full Self-Driving (FSD) software.

CheckMate 9LA showed a 26% overall survival benefit for metastatic NSCLC patients treated with nivolumab and ipilimumab plus chemotherapy over six years. The combination therapy was particularly ...